Kategoria BISAC: Business & Economics >> Industries - Pharmaceutical & Biotechnology

Lee Hood did that rarest of things. He enabled scientists to see things they couldn't see before and do things they hadn't dreamed of doing. Scientists can now sequence complete human genomes in a day, setting in motion a revolution that is personalizing medicine.

Hood, a son of the American West, was an unlikely candidate to transform biology. But with ferocious drive, he led a team at Caltech that developed the automated DNA sequencer, the tool that paved the way for the Human Genome Project. He captivated scientists with his almost religious fervor for the new biology enabled by...

Economic Evaluation of Pharmacy Services provides the latest on the trend to a more product-centered and service-centered practice, eschewing traditional economic evaluation techniques that focus on product-to-product comparisons in favor of evaluating processes that measure costs and health outcomes.

Complete with examples focusing on best practices, including various study designs, types of pharmacy services, and types of outcomes being evaluated, the book emphasizes case studies and examples that help readers understand economic evaluation techniques. Many of these...

Thom Burke is everything a scientist shouldn't be: brash, sophomoric, and reckless. A genius millennial born with a silver spoon; all the potential but none of the drive. But when his academic project is revoked by a big UCSF donor, Thom throws away his privilege, jeopardizing his career to produce an illegal gene-modifying drug that could change someone's belief in God . . . by making them become one. What Thom doesn't realize is that a version of this drug has already been created - weaponized - and its creators will do everything in their power to suppress its knowledge. Even...

This book provides a comprehensive overview of the new business context and marketing models for biotech companies, by analyzing best strategies and key success factors for innovation, portfolio management, commercialization and global expansion. It combines conceptual chapters and cases, in collaboration with senior executives from biopharma companies and leading consultancies, who can contribute significantly with the communication of the book to the customer networks. Chapters include: Biotechnology as an Innovation Driver; Startup Strategies; New Alliance and M&A Strategies; Precision...

The analytical approach of standard health economics has so far failed to sufficiently account for the nature of care.　 This has important ramifications for the analysis and valuation of care, and therefore for the pattern of health and medical care provision. This book sets out an alternative approach, which places care at the center of an economics of health, showing how essential it is that care is appropriately recognized in policy as a means of enhancing the dignity of the individual.

Whereas traditional health economics has tended to eschew value issues, this book...

The analytical approach of standard health economics has so far failed to sufficiently account for the nature of care.　 This has important ramifications for the analysis and valuation of care, and therefore for the pattern of health and medical care provision. This book sets out an alternative approach, which places care at the center of an economics of health, showing how essential it is that care is appropriately recognized in policy as a means of enhancing the dignity of the individual.

Whereas traditional health economics has tended to eschew value issues, this book...

Guide to EU Pharmaceutical Regulatory Law, which is updated annually to reflect the speed at which the rules and regulations change, provides a comprehensive and practical guide to, and analysis of, the current European Union (EU) Pharmaceutical Regulatory Regime. In the EU and its Member States, as elsewhere, the marketing of pharmaceuticals has become subject to an increasingly complex web of legislation and regulation, resulting from the intense scrutiny necessary to ensure that such essential products are not only efficacious but also safe. This useful volume lays out...

FDA's Drug Review Process and the Package Label provides a guide to pharmaceutical companies for writing FDA-submissions. This book covers all essential elements in FDA-approval including Clinical Study Reports, Investigator's Brochures, and the Common Technical Document (eCTD). Specifically, the book provides guidance to medical writers in the pharmaceutical industry for drafting FDA-submissions that will persuade FDA reviewers to grant approval to the drug. Containing excerpts copied from various package labels to demonstrate how the Sponsor's arguments, together with feedback,...